Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors-Reference-Cited by-同舟云学术

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors

Published:2022-02-23 Issue:2 Volume:17 Page:141-151
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Lee Matilda Xinwei,Wong Andrea L. A.,Ow Samuel,Sundar Raghav,Tan David S. P.,Soo Ross A.,Chee Cheng Ean,Lim Joline S. J.,Yong Wei Peng,Lim Siew Eng,Goh Boon Cher,Wang Lingzhi,Lee Soo Chin^ORCID

Funder

National Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11523-022-00867-0.pdf

Reference32 articles.

1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235(4785):177–82. https://doi.org/10.1126/science.3798106.

2. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke C, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. JNCI J Natl Cancer Inst. 2014;106:5. https://doi.org/10.1093/jnci/dju055.

3. Hsu JL, Hung M-C. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer. Cancer Metastasis Rev. 2016;35(4):575–88. https://doi.org/10.1007/s10555-016-9649-6.

4. Casalini P, Iorio MV, Galmozzi E, Ménard S. Role of HER receptors family in development and differentiation. J Cell Physiol. 2004;200(3):343–50. https://doi.org/10.1002/jcp.20007.

5. Roskoski R. The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol Res. 2014;79:34–74. https://doi.org/10.1016/j.phrs.2013.11.002.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

2. Varlitinib and Paclitaxel for EGFR/HER2 Co-Expressing Advanced Gastric Cancer: a Multicenter Phase Ib/II Study (K-MASTER-13);Cancer Research and Treatment;2024-04-29

3. Small Molecules against Metastatic Tumors: Concrete Perspectives and Shattered Dreams;Cancers;2023-08-18

4. Reduction of Blood Loss by Means of the Cavitron Ultrasonic Surgical Aspirator for Thoracoscopic Salvage Anatomic Lung Resections;Cancers;2023-08-11

5. Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach;Applied Biochemistry and Biotechnology;2023-07-20